Literature DB >> 20665395

Ocular sarcoidosis.

Robert P Baughman1, Elyse E Lower, Adam H Kaufman.   

Abstract

Ocular disease occurs in approximately a third of sarcoidosis patients. The rate of disease varies around the world, with Japanese sarcoidosis patients having ocular disease in more than 70% of cases. If untreated, ocular disease can lead to permanent visual impairment, including blindness. The most common manifestation is uveitis, with anterior involvement often being self-limiting, whereas posterior involvement can be chronic. The diagnosis of ocular sarcoidosis in patients with known sarcoidosis usually requires a specific examination by an ophthalmologist. For patients presenting with uveitis of unknown etiology, criteria have been proposed for diagnosing ocular sarcoidosis. The treatment of ocular disease ranges from topical therapy to systemic treatments such as methotrexate. Recent reports have demonstrated that monoclonal antibodies blocking tumor necrosis factor can be quite effective for chronic refractory ocular sarcoidosis. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665395     DOI: 10.1055/s-0030-1262213

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  20 in total

1.  Resolution of chronic ocular sarcoidosis with antimycobacterial therapy.

Authors:  Bradley W Richmond; Kyra Richter; Lloyd E King; Wonder P Drake
Journal:  Case Rep Intern Med       Date:  2014

Review 2.  Neuro-ophthalmic sarcoidosis.

Authors:  Robert P Baughman; Kenneth L Weiss; Karl C Golnik
Journal:  Eye Brain       Date:  2012-03-13

Review 3.  Cutting-edge issues in autoimmune uveitis.

Authors:  Roger A Levy; Francisco Assis de Andrade; Ivan Foeldvari
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 4.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 5.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 6.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

7.  Diagnostic management of patients with suspected ocular sarcoidosis.

Authors:  Kazuto Takada; Shuuichi Matsumoto; Eiji Kojima; Susumu Iwata; Kentarou Tanaka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

8.  Rituximab for refractory granulomatous eye disease.

Authors:  Elyse E Lower; Robert P Baughman; Adam H Kaufman
Journal:  Clin Ophthalmol       Date:  2012-10-05

9.  Sarcoidosis following Mycobacterium tuberculosis infection: Coincidence or consequence.

Authors:  J W T van Enschot; R H H van Balkom
Journal:  Respir Med Case Rep       Date:  2013-05-03

Review 10.  Current and emerging pharmacological treatments for sarcoidosis: a review.

Authors:  Scott H Beegle; Kerry Barba; Romel Gobunsuy; Marc A Judson
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.